CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 7,795 enrolled
Drug / intervention
Diagnostic examination for venous thromboembolismother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04400877
NCT04400877N/ACompleted
CompareCT.gov

Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic

University Hospital, Linkoeping·observational·Posted May 26, 2020·Updated Nov 18, 2021

In Brief

An observational study evaluating Diagnostic examination for venous thromboembolism for COVID-19 and 4 related conditions. Completed, enrolled 7,795 participants across 1 site.

Detailed Summary

The purpose of this study is to investigate the prevalence of venous thromboembolism in a regional health care system (Region Östergötland, Sweden) before and during the SARS-COV-2 pandemic. In a retrospective observational study, we will review patient data, diagnostic data and treatment data over a three-month period since the onset of the SARS-COV-2 pandemic. This data will be compared with data from the corresponding time frame during the years 2015 to 2019.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID-19, Venous Thromboembolism, Pulmonary Embolism, Deep Vein Thrombosis, SARS-CoV 2
CountriesSweden
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedMay 26, 2020
Enrollment StartJun 8, 2020
Primary CompletionJul 30, 2020
Study CompletionSep 30, 2020
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 6.1 years ago

Interventions

Diagnostic examination for venous thromboembolismother

Patients who have done a diagnostic examination for suspected VTE (pulmonary embolism och deep venous thrombosis) within the health care system of Region Östergötland. Patients without matching diagnostic examination but with a new diagnosis of pulmonary embolism or deep venous thrombosis during the same time periods will also be taking into account.